114 related articles for article (PubMed ID: 36316896)
1. Aberrant gene expression pattern in the glycolysis-cholesterol synthesis axis is linked with immune infiltration and prognosis in prostate cancer: A bioinformatics analysis.
Yuan Y; Song J; Wu Q
Medicine (Baltimore); 2022 Oct; 101(43):e31416. PubMed ID: 36316896
[TBL] [Abstract][Full Text] [Related]
2. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
Zhang Y; Zhu B; Cai Y; Zhu S; Zhao H; Ying X; Jiang C; Zeng J
BMC Cancer; 2022 Jan; 22(1):2. PubMed ID: 34980012
[TBL] [Abstract][Full Text] [Related]
3. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.
Karasinska JM; Topham JT; Kalloger SE; Jang GH; Denroche RE; Culibrk L; Williamson LM; Wong HL; Lee MKC; O'Kane GM; Moore RA; Mungall AJ; Moore MJ; Warren C; Metcalfe A; Notta F; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2020 Jan; 26(1):135-146. PubMed ID: 31481506
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Zhong PC; Shu R; Wu HW; Liu ZW; Shen XL; Hu YJ
Exp Biol Med (Maywood); 2021 Mar; 246(5):560-571. PubMed ID: 33243007
[TBL] [Abstract][Full Text] [Related]
5. Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Zhu Z; Qin J; Dong C; Yang J; Yang M; Tian J; Zhong X
Bioengineered; 2021 Dec; 12(1):4780-4793. PubMed ID: 34346836
[TBL] [Abstract][Full Text] [Related]
6. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract][Full Text] [Related]
7. Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
Chen YJ; Guo X; Liu ML; Yu YY; Cui YH; Shen XZ; Liu TS; Liang L
Front Immunol; 2022; 13():979521. PubMed ID: 36569910
[TBL] [Abstract][Full Text] [Related]
8. Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
Jiang J; Zheng Q; Zhu W; Chen X; Lu H; Chen D; Zhang H; Shao M; Zhou L; Zheng S
Aging (Albany NY); 2020 Jun; 12(11):10300-10316. PubMed ID: 32479426
[TBL] [Abstract][Full Text] [Related]
9. Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes.
Zhang J; Xiao X; Guo Q; Wei Z; Hua W
Comput Math Methods Med; 2022; 2022():9448144. PubMed ID: 35242216
[TBL] [Abstract][Full Text] [Related]
10. Metabolic deregulation in prostate cancer.
Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
[TBL] [Abstract][Full Text] [Related]
11. Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data.
Zhou Z; Tang J; Lu Y; Jia J; Luo T; Su K; Dai X; Zhang H; Liu O
Cancer Cell Int; 2023 Feb; 23(1):37. PubMed ID: 36841765
[TBL] [Abstract][Full Text] [Related]
12. Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.
Wei X; Michelakos T; He Q; Wang X; Chen Y; Kontos F; Wang H; Liu X; Liu H; Zheng W; Ferrone S; Zhang Y; Ferrone CR; Li X; Cai L
Oncologist; 2023 Nov; 28(11):e1031-e1042. PubMed ID: 37159555
[TBL] [Abstract][Full Text] [Related]
13. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Wang G; Liu X; Wang D; Sun M; Yang Q
Front Oncol; 2021; 11():636565. PubMed ID: 33842342
[No Abstract] [Full Text] [Related]
14. Molecular Subtypes of Ovarian Cancer Based on Lipid Metabolism and Glycolysis Reveals Potential Therapeutic Targets.
Wang X; Xie W; Zhao D; Liu M; Li W; Wang R; Cao L; Yu H
Front Biosci (Landmark Ed); 2023 Oct; 28(10):253. PubMed ID: 37919068
[TBL] [Abstract][Full Text] [Related]
15. Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis.
Deng W; Zhu P; Xu H; Hou X; Chen W
J Oncol; 2022; 2022():2014625. PubMed ID: 36213830
[TBL] [Abstract][Full Text] [Related]
16. Construction of Glycolytic Regulator Gene Signature to Predict the Prognosis and Tumor Immune Cell Infiltration Levels for Prostate Cancer.
Zhang L; Wang B; Wang ZS; Guo YL; Shen H
Comput Math Methods Med; 2022; 2022():9273559. PubMed ID: 35242214
[TBL] [Abstract][Full Text] [Related]
17. Promoting cell proliferation, cell cycle progression, and glycolysis: Glycometabolism-related genes act as prognostic signatures for prostate cancer.
Zhang Y; Mou Y; Liang C; Zhu S; Liu S; Shao P; Li J; Wang Z
Prostate; 2021 Feb; 81(3):157-169. PubMed ID: 33338276
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
Zhang E; He J; Zhang H; Shan L; Wu H; Zhang M; Song Y
Front Genet; 2020; 11():595657. PubMed ID: 33281882
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
